Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (41-50 of 348) with videos related to

Pageof 35
Sort By:
JAMA Network Open|June 9, 2020
Biomarker Testing in Lung Cancer-What Does It Mean?Hossein Borghaei, Martin J Edelman
Current Treatment Options in Oncology|January 15, 2003
Treatment options for brain metastases in patients with non-small cell lung cancerSadaf Taimur, Martin J Edelman
Clinical Lung Cancer|December 3, 2011
Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistanceMartin J Edelman, Marianna Shvartsbeyn
American Journal of Clinical Pathology|September 16, 2000
Diminished CD3 expression is useful for detecting and enumerating Sézary cellsJ Edelman, H J Meyerson
Journal of Molecular Biology|November 5, 1989
Linear optimization of predictors for secondary structure. Application to transbilayer segments of membrane proteinsJ Edelman, S H White
Planta|February 6, 2014
Phloem in carrot callusesA D Hanson, J Edelman
Planta|February 1, 2014
Photosynthesis by carrot tissue culturesA D Hanson, J Edelman
Translational Lung Cancer Research|March 26, 2015
Resistance to anti-angiogenic agents: a brief review of mechanisms and consequencesMartin J Edelman, Li Mao
Current Treatment Options in Oncology|June 12, 2002
Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resectionMartin J Edelman, Julie Schuetz
Expert Opinion on Investigational Drugs|April 3, 2012
EC145: a novel targeted agent for adenocarcinoma of the lungPamela Pribble, Martin J Edelman
Pageof 35

Showing results (41-50 of 348) with videos related to

Sort By:
Pageof 35
JAMA Network Open|June 9, 2020
Biomarker Testing in Lung Cancer-What Does It Mean?Hossein Borghaei, Martin J Edelman
Current Treatment Options in Oncology|January 15, 2003
Treatment options for brain metastases in patients with non-small cell lung cancerSadaf Taimur, Martin J Edelman
Clinical Lung Cancer|December 3, 2011
Epothilones in development for non--small-cell lung cancer: novel anti-tubulin agents with the potential to overcome taxane resistanceMartin J Edelman, Marianna Shvartsbeyn
American Journal of Clinical Pathology|September 16, 2000
Diminished CD3 expression is useful for detecting and enumerating Sézary cellsJ Edelman, H J Meyerson
Journal of Molecular Biology|November 5, 1989
Linear optimization of predictors for secondary structure. Application to transbilayer segments of membrane proteinsJ Edelman, S H White
Planta|February 6, 2014
Phloem in carrot callusesA D Hanson, J Edelman
Planta|February 1, 2014
Photosynthesis by carrot tissue culturesA D Hanson, J Edelman
Translational Lung Cancer Research|March 26, 2015
Resistance to anti-angiogenic agents: a brief review of mechanisms and consequencesMartin J Edelman, Li Mao
Current Treatment Options in Oncology|June 12, 2002
Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resectionMartin J Edelman, Julie Schuetz
Expert Opinion on Investigational Drugs|April 3, 2012
EC145: a novel targeted agent for adenocarcinoma of the lungPamela Pribble, Martin J Edelman
Pageof 35